机译:唑菌氏菌菌抗性的渐进式分散性:用CYP51A TR46 Y121F M172I T289A等位基因对A. Fumigatus菌株感染急性髓性白血病患者的致命侵袭性曲霉病
Tech Univ Dresden Inst Med Microbiol &
Hyg Dresden Germany;
Univ Med Ctr Gottingen Inst Med Microbiol Gottingen Germany;
Tech Univ Dresden Univ Hosp Carl Gustav Dept Internal Med 1 Dresden Germany;
Tech Univ Dresden Univ Hosp Carl Gustav Dept Pathol Dresden Germany;
Heidelberg Univ Mannheim Univ Hosp Dept Internal Med Hematol &
Oncol 3 Mannheim Germany;
Univ Med Ctr Gottingen Inst Med Microbiol Gottingen Germany;
Heidelberg Univ Mannheim Univ Hosp Dept Internal Med Hematol &
Oncol 3 Mannheim Germany;
Univ Med Ctr Gottingen Inst Med Microbiol Gottingen Germany;
Tech Univ Dresden Inst Med Microbiol &
Hyg Dresden Germany;
McGovern Med Sch Ctr Antimicrobial Resistance &
Microbial Genom Lab Mycol Res Houston TX USA;
Aspergillus fumigatus; azole resistance; hematopoietic stem cell transplantation; invasive aspergillosis; cyp51A mutation; breakthrough aspergillosis;
机译:唑菌氏菌菌抗性的渐进式分散性:用CYP51A TR46 Y121F M172I T289A等位基因对A. Fumigatus菌株感染急性髓性白血病患者的致命侵袭性曲霉病
机译:首次在西班牙的未使用过吡咯的患者中首次检测到因Cyp51A TR46 / Y121F / T289A引起的烟曲霉对吡唑类耐药的菌株
机译:烟曲霉TR46 / Y121F / T289A cyp51A唑耐药机制的基因型-表型复杂性
机译:烟曲霉中抗唑类药物的逐步分散:感染了cyp51A TR46 Y121F M172I T289A等位基因的烟曲霉菌株的急性髓样白血病患者的致命侵袭性曲霉病
机译:“首次检测西班牙azole-naive患者因Cyp51a TR46 / Y121F / T289a引起的烟曲霉耐药菌株”[New microbes New Infect 6(2015)33-34]